Verified Nov 2026
Other
·
Mountain View, California
·
Since 1999
NeuroPace is a medical device company headquartered in Mountain View, California, founded in 1999 and publicly traded under the ticker NPCE. It employs roughly 200 to 500 people and serves the medical sector, focusing on epilepsy care. Its RNS System is a brain-responsive neurostimulation platform for adults with drug-resistant focal epilepsy. In May 2026 the company announced FDA approval of its ECoG Assistant, an AI-driven tool for epilepsy care.
NeuroPace at a glance
Revenue
100.0M
Employees
200-500
Founded
1999
Headquarters
Mountain View, California
Ownership
Publicly traded (NASDAQ: NPCE)
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & strong
27 years in operation (founded 1999).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
NeuroPace is a medical device company headquartered in Mountain View, California, founded in 1999 and publicly traded under the ticker NPCE. It employs roughly 200 to 500 people and serves the medical sector, focusing on epilepsy care. Its RNS System is a brain-responsive neurostimulation platform for adults with drug-resistant focal epilepsy. In May 2026 the company announced FDA approval of its ECoG Assistant, an AI-driven tool for epilepsy care.
At a glance
Attribute | Detail |
|---|---|
Founded | 1999 |
Headquarters | Mountain View, California |
Employees | 200-500 |
Revenue | 100.0M |
Ownership | Publicly traded (NASDAQ: NPCE) |
Certifications | ISO 13485 |
What NeuroPace makes
The company holds ISO 13485 certification and markets the RNS System, an implantable neurostimulation platform for drug-resistant focal epilepsy.
Certifications
NeuroPace is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — linkedin.com
Latest developments
2026-08-11 — NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance | NeuroPace, Inc. (neuropace.com)
2026-05-29 — NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care | NeuroPace, Inc. (neuropace.com)
2026-03-03 — NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook | NeuroPace, Inc. (neuropace.com)
2025-12-17 — NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy | NeuroPace, Inc. (neuropace.com)
2025-11-24 — NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services | NeuroPace, Inc. (neuropace.com)
2025-06-04 — NeuroPace Secures Up to $75 Million in Debt Financing | NeuroPace, Inc. (neuropace.com)
Company details
NeuroPace is publicly listed under the ticker NPCE and in December 2025 filed a PMA supplement with the FDA seeking an expanded indication for the RNS System in idiopathic generalized epilepsy. NeuroPace was founded in 1999, has an estimated 200-500 employees, and is headquartered in Mountain View, California. On the LightSource stability read it is rated "Established & strong": 27 years in operation (founded 1999). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does NeuroPace do?
NeuroPace is a medical device company headquartered in Mountain View, California, founded in 1999 and publicly traded under the ticker NPCE. It employs roughly 200 to 500 people and serves the medical sector, focusing on epilepsy care. Its RNS System is a brain-responsive neurostimulation platform for adults with drug-resistant focal epilepsy. In May 2026 the company announced FDA approval of its ECoG Assistant, an AI-driven tool for epilepsy care.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, California (455 North Bernardo Avenue, Mountain View, California, 94043).
When was NeuroPace founded?
NeuroPace was founded in 1999.
How big is NeuroPace?
NeuroPace has an estimated 200-500 employees, with revenue in the 100.0M range.
Is NeuroPace publicly traded?
Publicly traded (NASDAQ: NPCE). Public financial figures are drawn from its filings.
What certifications does NeuroPace hold?
NeuroPace lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.